Afghanistan - 21,000 receive Covid-19 vaccine on daily basis: MoPH


(MENAFN- Pajhwok Afghan News)

KABUL (Pajhwok): The Ministry of Public Health (MoPH) says the number of people receiving Covid-19 vaccines has more than tripled.

India, China, the US, Italy, Austria, Sweden, France and some international organisations have delivered millions of doses of Covid vaccines to Afghanistan.

Officials of the former government had said that Afghanistan needed 42 million doses of such vaccines.

Dr. Javed Hajir, spokesman for MoPH, told Pajhwok Afghan News the number of people receiving the vaccine daily had increased from 7,000 to 21,000.

“Based on MoPH plans, we have stepped up the process of vaccination. About 21,000 people are vaccinated daily and the process is going on smoothly,” he added.

Hajir called on citizens, who had not yet received the vaccine, to get vaccinated in order to prevent the outbreak of the virus.

The total number of people vaccinated was more than 7.5 million, he said, adding that more than 3.4 million of them had been vaccinated since the fall of the previous administration.

Hajir called the role of the vaccine vital in preventing the virus and it was the only way to boost immunity against the disease.

As MoPH did not have adequate resources, he warned, if the citizens did not take the virus seriously and refused to receive the vaccine, the number of positive cases and deaths would munt.

According to him, diagnostic kits and PCR machines were available but advanced machines were needed to detect the virus.

Referring to the need for oxygen, he said they had decided to build 10 plants in 10 provinces with the help of UNICEF.

The ministry says Afghanistan has recorded more than 159,000 coronavirus cases and over 7,300 deaths.

sa/mud

MENAFN24012022000174011037ID1103582838


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.